Cover Image
市場調查報告書

肌肉骨骼疾病市場預測:各類型 (類風濕性關節炎,骨關節炎,乾癬性關節炎,僵直性脊椎炎等),不同治療,各地區

Musculoskeletal Diseases Market: By Type (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Others); By Treatment & By Region - (2016-2022)

出版商 IndustryARC 商品編碼 422370
出版日期 內容資訊 英文 147 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
肌肉骨骼疾病市場預測:各類型 (類風濕性關節炎,骨關節炎,乾癬性關節炎,僵直性脊椎炎等),不同治療,各地區 Musculoskeletal Diseases Market: By Type (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Others); By Treatment & By Region - (2016-2022)
出版日期: 2017年09月11日 內容資訊: 英文 147 Pages
簡介

本報告提供全球肌肉骨骼疾病市場相關調查分析,提供市場形勢,市場動態,策略性分析,市場分析 (各市場區隔),再加上主要企業等相關的系統性資訊。

第1章 肌肉骨骼疾病市場:市場概要

第2章 摘要整理

第3章 市場形勢

  • 市場佔有率分析
  • 比較分析
  • 產品基準
  • 終端用戶簡介
  • 財務分析前五名

第4章 肌肉骨骼疾病市場:市場動態

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題
  • 波特的五力分析

第5章 肌肉骨骼疾病市場:策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供給業者·經銷商

第6章 肌肉骨骼疾病市場:各類型

  • 類風濕性關節炎
  • 骨關節炎
  • 骨質疏鬆症
  • 乾癬性關節炎
  • 僵直性脊椎炎
  • 纖維肌痛

第7章 肌肉骨骼疾病市場:不同治療

  • 生技藥品
  • 皮質類固醇 (CS)
  • 副甲狀腺素 (PTH)
  • 蛋白質療法
  • 選擇性雌激素受體調節 (SERM)
  • 人工骨移植
  • 複合移植
  • 脫鈣骨基質
  • BMP

第8章 肌肉骨骼疾病市場:各地區

  • 歐洲
  • 亞太地區
  • 北美
  • 其他

第9章 肌肉骨骼疾病:市場熵

第10章 企業簡介

  • AB Sciences.
  • AbGenomics International.
  • Alder BioPharmaceuticals
  • Amgen Astellas BioPharma.
  • Antares Medical Services
  • Lexicon Pharmaceuticals
  • LG Life Sciences.
  • OrthoTrophix
  • Tarsa Therapeutics
  • PhytoHealth Corporation.

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Musculoskeletal diseases/disorders (MSDs) are diseases of muscles and related ligaments, and other connective tissues and bones. Some of the most common musculoskeletal diseases are back pain, osteoarthritis, rheumatoid arthritis, osteoporosis, septic arthritis, gout, myasthenia gravis, systemic lupus erythematosus (SLE), and some others. Globally, development of efficient and advance technology, rise in the awareness among people, increasing government initiative across the globe, growing healthcare expenditure, and growing development and commercialization of pipeline drugs are the prime growth drivers of global Musculoskeletal Diseases market. In addition, increase in adoption of Musculoskeletal Diseases drugs in emerging economies such as China, India and others, will create new opportunities for global Musculoskeletal Diseases market. However, higher cost of the research and development, complex government approval process and risk of side effects are the key restraints for global Musculoskeletal Diseases market.

Geographically Americas dominated global Musculoskeletal Diseases market, because of over-use of weak muscles, tendons, or ligaments, vigorous vocational activities. Asia Pacific is projected to have fastest growth, owing to prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and degenerative disc diseases increase in developing nations such as China, and India in this region. Among all the treatments, biologics procedures has the highest market share in global Musculoskeletal Diseases market due to higher prevalence of cancer patients.

This report identifies the global Musculoskeletal Diseases market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Musculoskeletal Diseases market.

This report segments global Musculoskeletal Diseases market based on type, treatment, and regional market as follows:

Musculoskeletal Diseases Market, By Type: Rheumatoid arthritis, Osteoarthritis, Osteoporosis, and Others

The report has focused study on Musculoskeletal Diseases market by basis of end-user such as: Biologics, Corticosteroids, Parathyroid Hormone, and Others

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Musculoskeletal Diseases market. Some of the major companies' profiles in detail are as follows:

AB Sciences.

AbGenomics International.

Alder BioPharmaceuticals

Amgen Astellas BioPharma.

Antares Medical Services

1. Musculoskeletal Diseases Market - Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Musculoskeletal Diseases Market- Market Forces

  • 4.1. Drivers
    • 4.1.1. Development of efficient and advance technology
    • 4.1.2. development and commercialization of pipeline drugs
  • 4.2. Restraints
    • 4.2.1. Higher cost of research and development
  • 4.3. Opportunities
    • 4.3.1. Emerging economies
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Musculoskeletal Diseases Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Musculoskeletal Diseases Market, By Type

  • 6.1. Rheumatoid arthritis
  • 6.2. Osteoarthritis
  • 6.3. Osteoporosis
  • 6.4. Psoriatic arthritis
  • 6.5. Ankylosing spondylitis
  • 6.6. Fibromyalgia

7. Musculoskeletal Diseases Market, By Treatment

  • 7.1. Biologics
  • 7.2. Corticosteroids
  • 7.3. Parathyroid hormone
  • 7.4. Protein therapy
  • 7.5. Selective estrogen receptor modulators
  • 7.6. Synthetic bone graft
  • 7.7. Composite grafts
  • 7.8. Demineralized bone matrix
  • 7.9. BMPS

8. Musculoskeletal Diseases Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Musculoskeletal Diseases - Market Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. AB Sciences.
  • 10.2. AbGenomics International.
  • 10.3. Alder BioPharmaceuticals
  • 10.4. Amgen Astellas BioPharma.
  • 10.5. Antares Medical Services
  • 10.6. Lexicon Pharmaceuticals
  • 10.7. LG Life Sciences.
  • 10.8. OrthoTrophix
  • 10.9. Tarsa Therapeutics
  • 10.10. PhytoHealth Corporation.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top